Is there hope of recovery for people suffering from dementia or Alzheimer’s disease, a type of dementia that affects memory, language, and thought? Scientific researchers will answer with a resounding yes.
The heartening news from the UK Dementia Research Institute is that there is a chance for the brain to re-wire itself and for lost mental ability to be restored once the progress of the burdensome disease is halted.
Belgian molecular biologist Bart De Strooper, director of Britain’s £250 million Dementia Research Institute (launched in December), expressed optimism that by 2025, while dementia and related disorders may not yet be cured, groups of patients can be treated in much the same way HIV-Aids sufferers are in the present age. Meantime, the U.S. National Institutes of Health tweeted that the public-private collaboration effort Brain Initiative launched by former U.S. President Barack Obama in 2013 will continue to offer insights for treating a wide variety of brain disorders that include Alzheimer’s disease.
For his part, Professor De Strooper will converge a multi-disciplinary team of doctors, biologists, engineers and data specialists from centers across the UK. While not discounting the new wave of amyloid-targeting drugs undergoing clinical trials, Professor De Strooper disclosed that the new institute’s approach is to view dementia as a complicated, multi-factorial disease – various factors including inflammation, biochemistry, cellular changes are likely to have an influence.
Addressing the Alarming Statistics
The Alzheimer’s Association based in Chicago, Illinois tweeted that current statistics surrounding Alzheimer’s are staggering. The upswing of Alzheimer’s disease in the U.S. has prompted the association to categorize the illness as a national public health threat.
It published in the 2016 Alzheimer’s Disease Facts and Figures that regardless of the cause of death, among people age 70, 61 percent of those with Alzheimer’s are expected to die before age 80 compared with 30 percent of people without Alzheimer. Indeed, the burden of Alzheimer’s has increased more dramatically in the United States than other diseases in recent years.
In other news, Mayo Clinic, an integrated education and research institution that has provided helpful information about various kinds of diseases, likewise announced that it was awarded $1.6 million in Alzheimer’s disease research state grants. It is hoped that investment will spur further research that can translate into treatments that can change lives, Mayo Clinic Vice President Dr. Gianrico Farrugia expressed.